Human immunodeficiency virus type 1 (HIV-1) is characterized by extensive genomic heterogeneity. Independent isolates from North America differ in almost 10% of amino acid residues in env, while isolates from Africa can differ in up to 25% of these sites (1, 30) . In common with visna virus and equine infectious anemia virus (3, 23) , HIV-1 also shows variability within infected individuals. Genetic differences have been observed among consecutive isolates and, concurrently, within the same isolate established from the same patient (9, 26) . It has previously been suggested in the case of the other lentiviruses that sequence change may be immunologically driven, natural selection favoring the spread of variants that escape from immune surveillance during the course of the infection (2, 20) . If sequence changes in HIV occur under the influence of selection by the host immune response, their identity and rate of occurrence will be important for the effort to develop an effective vaccine.
Previous attempts to estimate the rate of evolution of the HIV-1 genome have been based on analyses of sequence data obtained from viral isolates made at different times. One group (29) suggested from an analysis of env sequences that HIV-1 and HIV-2 may have diverged as recently as 40 years ago. Others (34; P. M. Sharp and W.-H. Li, Nature [London] 336:315, 1988), using data on gag and pol as well, suggested that the two viruses diverged from 150 to 300 years ago. Hahn et al. (9) obtained three isolates from the same patient over an 18-month period and analyzed the env gene sequences obtained in a similar way. Their estimate of the rate of sequence change is compatible with all of these.
We have been studying HIV sequence change in a group of patients who became infected during 1984 after exposure * Corresponding author.
to factor VIII concentrate prepared from donated blood by the Scottish National Blood Transfusion Service (SNBTS). A single batch of factor VIII was implicated in the seroconversion of these patients (17) . Of a total of 32 patients exposed to the batch, 18 seroconverted. These patients received, on average, significantly more units of the putative infected batch than those who did not (17) . This batch was prepared from plasma collected at a time when HIV-1 was only beginning to enter the donor population, as indicated by the low incidence of anti-HIV-1-positive sera among samples collected at that time (24) . For both these reasons it has been considered that very few HIV-infected individuals could have contributed to the infected plasma pool.
We have analyzed HIV sequences in samples donated in the summer of 1989 by eight members of this cohort and one other HIV-infected hemophiliac. We have used a double polymerase chain reaction (PCR) procedure to obtain the nucleotide sequence of individual provirus molecules (27) . This approach is not subject to any bias due to virus culture in vitro nor to possible errors introduced by Taq polymerase (31) . Between 5 and 14 sequences from each patient studied were obtained from one region of gag encoding part of p24 and from two regions of env; one, V4-V5, which includes the CD4-binding domain (4, 12) and the flanking hypervariable regions (V4 and V5; 19) , and another which spans the immunodominant or V3 loop (19, 25) . We have investigated the evolutionary relationships among sequences from different patients and found that they are much more closely related to each other than are sequences from independent isolates or sequences obtained from the noncohort control. We will present evidence that at least six of the cohort patients were infected by virus originating from a single individual donor. On this basis we have estimated the extent of divergence in these regions of the HIV-1 genome among this group of patients and the rate of sequence change. PCR amplification. DNA samples were prepared from at least 5 x 106 peripheral blood mononuclear cells (PMBCs). DNA preparation, amplification by double PCR, and quantification by limiting dilution were carried as described previously (27) . All DNA extractions and amplification reactions carried appropriate negative controls (blood from seronegative, low-risk group blood donors) to detect contamination at every stage in the procedure. To permit the same sample to be amplified in two regions, the first reaction used the positive-sense outer V3 primer -a-with the antisense outer V4-V5 primer -h-to amplify an 858-bp fragment. The second reaction amplified an aliquot of the product using the inner V3 sense -b-and inner V4-V5 antisense -g-primers to give a 657-bp fragment. The final amplifications used the inner V3 and V4-V5 primers in separate reactions. V3 and V4-V5 DNAs amplified by this modified procedure are equivalent to those prepared by conventional amplification of separate samples by the double PCR.
Determination of sequence. The double PCR procedure allows the amplification of segments of single isolated molecules of HIV-1 provirus to yield quantities sufficient for direct sequencing (>500 ng of DNA). The DNA product of PCR amplification was purified by using Gene-Clean (Bio 101 Inc.). From 50 ,ul of PCR amplification a yield of 500 ng was routinely achieved, of which 100 ng was used for each set of sequencing reactions. Sequencing was carried out by using Sequenase protocols (U.S. Biochemicals) except as follows. The standard annealing mix was adjusted to 10% dimethyl sulfoxide (33) Sequences were collected and aligned using the University of Wisconsin GCG package (5) and the Needleman and Wunsch alignment algorithm (21) . Final alignments were adjusted by eye, and their quality was assessed by the reduction of the total branch lengths of the phylograms generated under the assumption of maximum parsimony.
Because of the volume of data available it was not practicable to perform a maximum likelihood analysis of the sequence data itself. The data were therefore transformed into a distance matrix, using a modification of the distance algorithm of Kimura (10) which takes into account the base composition of the DNA under study (11) . Comparison of results obtained by maximum likelihood analysis of subsets of the data showed good agreement with those given by using the distance matrix approach.
Phylogenetic trees were generated from the distance matrix by the method of Fitch and Margoliash (7) , using the Phylip package (6) distributed by J. Felsenstein. Final tree topologies were permuted by using a branch swapping algorithm to minimize overall length.
Nucleotide sequence accession number. The sequences presented in this report have been submitted to GenBank under accession number M36997.
RESULTS
Nucleotide sequences from PBMCs. In Fig. 1 we present 74 nucleotide sequences of the V4-V5 region obtained directly from double PCR-amplified PBMC DNAs of eight members of the Edinburgh hemophiliac cohort and one control patient, also a hemophiliac, who was infected in the United States. We include for comparison published sequences from eight independent HIV isolates. In Fig. 2, 39 sequences of the V3 region obtained similarly from five of the cohort members and the control patient are given. Each sequence represents an individual provirus molecule, isolated by limit dilution of the PBMC DNA. Because it is possible to amplify more than one region of the same molecule using this procedure, in many cases we have been able to obtain sequences of both V4-V5 and V3 from the same provirus. The sequences were aligned by the introduction of gaps as necessary. As the positions and lengths of gaps were constrained to preserve the reading frame, the alignment was initially carried out on the deduced amino acid sequences.
Absence of inactivating substitutions. The sequences of the V4-V5 region exhibit extensive variation due both to nucleotide substitutions and to insertion-deletion events, as indicated by the need to introduce a large number of gaps in the alignment (Fig. 1 ). Despite this, only two inactivating substitutions were observed in the 74 sequences (each approximately 300 bp in length). There are no inactivating mutations among the 39 V3 region sequences shown in Fig. 2 (325 bp in length). We have also determined 33 sequences of a 220-bp segment of the gag (p24) gene (coordinates 1407 to 1646 in the HXB2 sequence) from five cohort and three noncohort patients (data submitted to Los Alamos AIDS data base). No inactivating mutations were observed in these sequences. In this data set, therefore, the frequency of inactivating substitutions is approximately 1 in 20 kb. These results suggest that in these regions of gag and env there is strong selection for maintenance of a continuous reading frame. The strength of selection favoring the existing amino acid sequence is indicated by the ratio of synonymous to nonsynonymous substitutions (13, 14) , which we have estimated by using the procedure of Li et al. (16) . For gag the ratio is 6.7, indicating that the amino acid sequence is under significant constraints. For the V4-V5 and V3 regions the ratios are 1.3 and 0.92, respectively. These extremely ..... CCCATCAGAGGACAA ATTAGATGTTCATCA AATATTACAGGGCTG VOL. 64, 1990 PARALLEL SEQUENCE CHANGES IN HIV-1 6225 -
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We have calculated the overall frequency of transitions and transversions for all pairwise comparisons among these sequences. The ratio of transition to transversion substitutions was 1.79 for the V4-V5 region and 1.50 in the gag sequence, comparable to ratios observed for mammalian genes (22) .
Evolutionary relationships among HIV sequences. Examination of Fig. 1 reveals, Nucleotide distances of HIV sequences within and between patients. We estimated the evolutionary divergence for all pairwise comparisons among the sequences in Fig. 1 and 2 . We then grouped the estimates into (i) comparisons between sequences derived from a single patient and (ii) comparisons between sequences taken from each pairwise combination of patients, and we examined the distribution of distances for each. For most groups the distribution of estimates was relatively narrow and unimodal (data not shown), but for some, specifically for patient 74 and for the group of HIV isolates, a wider spread was observed. The group means are given in Tables 1 and 2 .
The mean nucleotide distance in V4-V5 between HIV isolates (17.0%) was considerably higher than that for the intrapatient comparisons. The mean intrapatient distance among all patients was 5.5% (range 1 to 9.2%). Amnong the Edinburgh patients, the mean nucleotide distances of several interpatient pairs, e.g., 5 .6% for patients 83 and 84, were within this range. However, the U.S.-infected control (patient 12) had very distinct HIV sequences, as did patient 82. In V3, for which the mean distance within patients was similar (4.2%), all the nucleotide distances between patients were much greater. It should be noted that our estimates of divergence are based solely on the extent of nucleotide substitution. In regions such as V4, for which DNA insertion and deletion events are also frequent, these will be underestimates of the overall mutation distance.
In Table 3 we present estimates obtained in a similar fashion for the region sequenced in gag. As expected from J. VIROL. Fig. 3 , using the data summarized in Table 2. previous work, the overall mean within-patient diversity is much lower, at only 1.65%. It is interesting to note that the patient showing the greatest diversity in this region also had relatively high diversity in env, but the figures for gag are too low to contain much information on phylogenetic relationships.
Divergence of HIV-1 sequences within the hemophiliac cohort. The phylogenetic analyses presented in Fig. 2 indicate that the sequences obtained from most of these patients are distinct from those of any other, despite the close relationships between those from several patients. Thus, the evolutionary divergence that is represented by the within-patient nucleotide distances has occurred during the period of infection, which is approximately 5 years, although we cannot know exactly when divergence occurred within that time. If we assume that divergence occurred immediately after infection, then we might estimate the rate of sequence change in these regions of gpl20 by dividing the mean nucleotide distance between sequences from the same patient by the length of time those sequences might have been evolving independently (twice the time since infection). Using the data in Table 1 , we would obtain a mean estimate of 0.55% per annum.
An estimate of sequence change in HIV-1 obtained in this way depends also on the assumptions (i) that the rate of change is constant and (ii) that it is the same in each patient. An estimate which did not depend on these assumptions would be preferable. To avoid the need to make these assumptions, we have adopted a model of HIV evolution in the cohort with which we can use information on the nucleotide distances between patients as well as within them (Fig. 5) . As indicated above, six of the patients studied show interpatient mean distances which overlap the within-patient diversity. In addition, these six patients share a specific Data from the group of eight independent HIV-1 isolates whose sequences are included in Fig. 1 . d HIV-1 provirus abundance in each PBMC DNA sample was estimated by limit dilution (27) .
Clinical status of each patient at the time of sampling. f Given in error as CDC stage II previously (27) .
VOL. 64, 1990 Two components comprise the total sequence change in each patient (Fig. 5) , one representing the within-patient divergence and a second comprising the sequence change that occurred prior to the time when the sequences present within the patient diverged from each other. In the case of patient A ( Table 4 . AB, AC, and BC, respectively. The unknown branch length d can be estimated from any of 10 sets of three-way comparisons. We have taken the mean of all 10 and give these as our estimates for V4-V5 and V3 (Table 4) . The branch components, e.g., a and d for patient A (Fig. 5) , can then be summed for each patient to give the total HIV sequence evolution in these patients. We have also calculated the branch lengths for the gag sequences for five of the patients in the same way (Table 4) .
By this approach we estimate the mean branch length separating the sequences from these patients to be 4.12% (V4-V5) and 4.82% (V3). We have used both synonymous and nonsynonymous substitutions to obtain this estimate, because their ratio is close to unity in these regions. The range of branch lengths varies approximately twofold over patients in V4-V5 but less so in V3; however, fewer patients can be compared in that region. Comparable branch lengths in gag are much shorter because of the low frequency of amino-acid replacement substitutions (Table 4) .
The extent of HIV sequence evolution in each patient is depicted in Fig. 6 . Triangles represent the divergence observed between sequences in the same sample (Fig. 5, a) . The vertical distance below the triangles represents prior divergence (Fig. 5, d ) from the sequence in the infected donor (represented by the origin). Thus, patients 79 and 87, who show the greatest intrapatient nucleotide distance of this group, also contain sequences that appear to be most distant from the origin. In contrast, patient 84 shows the lowest intrapatient nucleotide distance but a greater change from the origin than does patient 79. All three patients were Centers for Disease Control (CDC) stage IVC2 when sampled, and all patients had been infected for approximately 5 years. IG. 6 . HIV-1 sequence evolution among six hemophiliacs infected by exposure to a common batch of factor VIII. The estimates of mean branch length in Table 4 are plotted as a set of independently evolving virus populations which shared a common ancestor in the infected donor. Vertical distance is directly proportional to the estimated mean sequence change in each patient. The inverted triangles indicate the observed intrapatient sequence divergence for each patient (Fig. 5, a) . The vertical distance from the root to the (inverted) apex of each triangle indicates the inferred evolutionary change (Fig. 5, d ).
(72-amino-acid) segment of the first exon of the tat gene, Meyerhans et al. (18) observed four inactivating mutations in 35 sequences (total of 7,000 nucleotides, approximately).
This gives a frequency of 5 x 10-4 per nucleotide, which is about 10-fold higher than the 5 x 10-5 we have observed in 42,000 nucleotides sequenced from gag and env. A number of defective gag and env sequences have been described by the same group, but these were obtained from isolates propagated in tissue culture (8). Meyerhans et al. (18) also observed a further eight variants which gave no Tat activity in vitro. It was suggested that up to a third of tat genes, and perhaps a majority of HIV-1 proviruses are inactive. However, the data we have presented indicate that the extension to the rest of the HIV genome is not justified. In the regions of gag-and env-encoding structural proteins that we have sequenced, the frequency of defective sequences is much lower than that found in tat.
Our earlier work (27) led us to conclude that the copy number of HIV-1 provirus in circulating PBMCs was close to one. We argued that functional complementation would not be possible within an infected cell and so we would not expect a high proportion of proviruses to be defective because they would continually be exposed to a strong selection for function. The A total of 32 patients were exposed to this batch, and the probability of seroconversion was significantly associated with the number of vials used (17) . Whereas 8 of 9 patients who used more than 40 vials became infected, only 7 of 23 who used less did so. In addition, it seems likely that only a very few HIV-infected individuals contributed to that batch as only small numbers of HIV seropositives have been identified among sera obtained from the major risk groups in the collection area during 1983, when the plasma pool was being collected (24) . On both counts, the implicated batch of SNBTS factor VIII does not appear to have been highly infectious.
As documented here and elsewhere (8, 9, 18, 26) , HIVinfected individuals harbor many different viral sequences, but those present at any one time usually bear a close relationship to each other. In the case of the implicated factor VIII batch, the patients who seroconverted may have received a minimum infectious dose. Sampling small numbers of HIV sequence variants in this way from those present in the infected donor(s) could cause them to be unevenly distributed among the recipients. The hemophiliac patients studied might therefore have become infected with viruses whose genomes were already differentiated. However, if members of the cohort were infected with virus which originated from a single individual, they would possess HIV sequences that, although not identical, would be much more similar to each other than to those from unrelated individuals. If more than one infected donor contributed to the infected batch, then two or more groups of sequences might be distributed among the recipients.
Pattern of HIV sequence relationships within the Edinburgh hemophiliac cohort. We have analyzed a total of 74 sequences from the CD4-binding domain of env and flanking hypervariable regions V4 and V5 (19), which we obtained by limit dilution, amplification, and direct sequencing of the product (27) . The phylogenies given in Fig. 3 and 4, which were obtained from nucleotide distance matrices, were similar to others produced by a maximum-likelihood procedure (see Materials and Methods). All the phylogenetic analyses showed, first, that sequences from the same patient are more similar to each other than to those from different patients. Second, the noncohort patient, who was infected in the United States from commercial factor VIII, has sequences which are very distinct from those of the cohort patients, as are all the published sequences from viral isolates. Third, in the V4-V5 region, six of the eight Edinburgh-infected hemophiliacs have sequences which are particularly closely related to each other, while two others (no. 82 and 74) have sequences which are less so.
Diversity within patients. The nucleotide diversity observed within individual patients varied over a wide range. Within the V4-V5 region the mean nucleotide distance between sequences obtained from patient 84 was 1%, while that from patient 74 was 9.2%. The overall mean sequence divergence within patients was 5%. We have examined the distribution of nucleotide distances among sequences from the same patients by plotting histograms of the results of all pairwise sequence comparisons (data not shown). We would in this way be able to detect whether there was evidence for any patient, and patient 74 in particular, having been infected with virus originating from more than one donor, which would be revealed as a bimodal distribution of nucleotide distances (see above). We did not detect such bimodality in any patient. There is therefore no evidence from the VOL. 64, 1990 )t (Table 4) , and most of the difference between patients in terms of the overall lengths is contributed by the sevenfold range in nucleotide diversity among sequences within each sample. This could have come about through differences between patients in the rate of nucleotide substitution per virus replication cycle or the rate of virus replication, or both. In either case, in view of the genetic similarity of the virus which infected these patients, the similarity in initial dose, and the duration of the infection, the difference is likely to reflect differences in the response of the host to the virus.
The value of the approach we have taken is that, while it is impossible to determine exactly how long ago the sequences within each sample diverged from each other and it may be different for different patients, the overall divergence across patients infected by a single donor has accumulated over approximately 5 years. The HIV sequences received by each of the six patients shown in Fig. 6 , although recently diverged, would not have been identical at the time of infection. The extent of this prior divergence, and consequently the time since divergence from the common ancestral sequence, is estimated by the difference between the mean inter-and intrapatient divergence for this group, 8.3 and 4.6%, respectively. The difference of 3.7% is lower than the mean intrapatient diversity, which implies that at least half (56%) of the divergence between sequences from different patients, indicated by the branch lengths in Fig. 6 and Table 4 , has occurred in the 5 years since infection, the remainder having occurred in the infected donor. From this we estimate the mean rate of nucleotide sequence change in the V4-V5 and V3 regions to be 0.41 and 0.48% per annum, respectively. The total time since the cohort sequences diverged is estimated to be approximately 9 years.
Two earlier estimates of the rate of sequence change in the env gene of HIV-1, 0.92% (15) and 1.2% (29) on the basis of sequences from virus isolates, are higher than the estimate obtained here. Closer comparisons cannot be drawn however, as there are considerable differences between conserved and variable regions of the gene (15) . Two aspects of our data suggest that caution should be exercised in extrapolating to obtain times of divergence between virus sequences from different sources. First, the twofold range over patients indicates that estimates based on individual patients or isolates (29) will be subject to large errors. Second, and perhaps more important, the extreme localization of much of the variability to very small regions implies that the nucleotide distance between highly diverged sequences will be consistently underestimated because of saturation effects which will not be adequately taken into account in wholegene analyses.
Nevertheless, taking only the patients within our group, we can estimate three divergence times. First, the time since the divergence of the cohort sequence from the related Edinburgh sequence found in patient 74 would be approximately 14 years (against 9 years for the cohort). Second, the time since divergence of the cohort sequence from the U.S.-derived sequence found in patient 12 could be as much as 30 years, and third, the time since the divergence from the sequence found in patient 82 (and two others, as indicated above) could be about 24 years. A reasonable interpretation would be that two HIV-1 lineages which were transmitted independently from North America are currently represented in Scotland and have been transmitted to these hemophiliacs.
